Skip to main content
OpenTrials

Clinical trial condition

Recurrent Childhood Acute Myeloid Leukemia

Explore clinical trials studying Recurrent Childhood Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

60 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Childhood Acute Myeloid Leukemia trial results

Completed

Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT02642965

Conditions
Acute Myeloid Leukemia Post Cytotoxic Therapy, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
View all 73 locations
View Trial Details
Completed

Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant

NCT01817075

Conditions
Bacterial Infection, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Miller Children's and Women's Hospital Long Beach Long Beach, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Valley Children's Hospital Madera, California, United States
View all 59 locations
View Trial Details
Completed

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia

NCT00860574

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +50 more
Locations
  • University of Colorado Denver, Colorado, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia

NCT01307579

Conditions
Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +42 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 179 locations
View Trial Details
Completed

Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

NCT01445080

Conditions
Blast Crisis, Blastic Phase, Bone Marrow Diseases, +33 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 25 locations
View Trial Details
Completed

Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation

NCT01371656

Conditions
Acute Leukemias of Ambiguous Lineage, Agranulocytosis, Bacterial Infection, +30 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
  • City of Hope Medical Center Duarte, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 84 locations
View Trial Details
Completed

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

NCT01154816

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hepatoblastoma, +33 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 105 locations
View Trial Details

Related conditions